Pivotal Life Sciences Congratulates MapLight Therapeutics and Evommune, Inc. on Successful IPOs

Pivotal Life Sciences Holdings LLC published this content on December 03, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 23, 2026 at 07:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]